Filter
404
Text search:
in
vitro
diagnostic
tests
Featured
61
92
Language
Document type
188
112
40
37
11
10
4
1
1
Countries / Regions
21
10
10
9
8
5
5
5
5
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
91
88
33
12
12
8
Toolboxes
64
54
53
29
21
18
11
11
9
9
7
5
2
2
2
2
1
1
1
La détection directe des protéines virales du SRAS-CoV-2 (antigènes) dans les écouvillons nasaux et autres sécrétions respiratoires à l'aide de tests immunologiques à flux latéral (également appelés
...
Lateral-flow rapid diagnostic tests (RDTs) continue to play a vital role in global health in the
...
PQDx 0181-031-00
WHO PQ Public Report
March/2017, version 3.0
PQDx 0198-071-00
WHO PQDx PR
April/2016, version 2.0
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij
...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive
...
This WHO information note provides an updated list of recommended criteria for selecting RDTs for malaria, and highlights the performance of RDTs evaluated by the WHO malaria RDT product testing programme. It also provides an overview of additional considerations
...
orientations provisoires, 25 juin 2021. Des tests de diagnostic rapides et précis sont un outil essentiel pour prévenir et contrôler la propagation du COVID-19. Ce document décrit les recommanda
...
Technical specifications for selection of essential in vitro diagnostic tests for SARS-COV-2, 14
...
This document provides brief information answering common questions regarding COVID-19 diagnostic tests and how to prioritize them to the patients most in
...
PQDx 0006-005-00 WHO
PQDx PR
February/2016, version 2.0
Information Note
Advice for countries using or planning
to introduce dual HIV/syphilis RDT in antenatal services and other testing sites.
WHO/RHR/17.01
The purpose of this TPP is to communicate the minimum and ideal characteristics desired to meet the need for discriminating low levels of risk for transmission, i.e. targeted prevalence thresholds in the surveyed areas. An
...
PQDx 0018-010-00 WHO
PQDx PR
July/2016, version 3.0
Lignes directrices.
Collection Avis et Rapports.
Interim Technical Note
